The TFDA monitors drug side effects in Taiwan through a pharmacovigilance system that requires manufacturers to report adverse events and submit Periodic Safety Update Reports (PSURs). The TFDA collaborates with healthcare providers to track incidents and may conduct inspections or request further studies based on findings, ensuring continued drug safety and public health protection.